These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 2843624

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A novel action of morphine in the rat locus coeruleus: persistent decrease in adenylate cyclase.
    Beitner DB, Duman RS, Nestler EJ.
    Mol Pharmacol; 1989 May; 35(5):559-64. PubMed ID: 2498635
    [Abstract] [Full Text] [Related]

  • 3. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
    Puttfarcken PS, Werling LL, Cox BM.
    Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
    [Abstract] [Full Text] [Related]

  • 4. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
    Costa T, Klinz FJ, Vachon L, Herz A.
    Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042
    [Abstract] [Full Text] [Related]

  • 5. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
    Mostany R, Díaz A, Valdizán EM, Rodríguez-Muñoz M, Garzón J, Hurlé MA.
    Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. G(z) can mediate the acute actions of mu- and kappa-opioids but is not involved in opioid-induced adenylyl cyclase supersensitization.
    Tso PH, Wong YH.
    J Pharmacol Exp Ther; 2000 Oct; 295(1):168-76. PubMed ID: 10991975
    [Abstract] [Full Text] [Related]

  • 8. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus.
    Nestler EJ, Tallman JF.
    Mol Pharmacol; 1988 Feb; 33(2):127-32. PubMed ID: 3340078
    [Abstract] [Full Text] [Related]

  • 9. Delta opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacy.
    Remmers AE, Clark MJ, Liu XY, Medzihradsky F.
    J Pharmacol Exp Ther; 1998 Nov; 287(2):625-32. PubMed ID: 9808689
    [Abstract] [Full Text] [Related]

  • 10. Blockade of D-2 dopamine receptors strongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors.
    Schoffelmeer AN, Hansen HA, Stoof JC, Mulder AH.
    J Neurosci; 1986 Aug; 6(8):2235-9. PubMed ID: 3018189
    [Abstract] [Full Text] [Related]

  • 11. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY, Friedman E, Olmstead MC, Burns LH.
    Neuroscience; 2005 Aug; 135(1):247-61. PubMed ID: 16084657
    [Abstract] [Full Text] [Related]

  • 12. The new positive inotrope sulmazole inhibits the function of guanine nucleotide regulatory proteins by affecting GTP turnover.
    Ramkumar V, Stiles GL.
    Mol Pharmacol; 1988 Dec; 34(6):761-8. PubMed ID: 2849044
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
    Yoshimura M, Ikeda H, Tabakoff B.
    Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Naturally occurring opioid receptor agonists stimulate adenylate cyclase activity in rat olfactory bulb.
    Onali P, Olianas MC.
    Mol Pharmacol; 1991 Apr; 39(4):436-41. PubMed ID: 1673223
    [Abstract] [Full Text] [Related]

  • 19. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL, Tsai AW, Law PY.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [Abstract] [Full Text] [Related]

  • 20. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY, Loh HH.
    Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.